Checking Up on GSK in China

When thinking through an FCPA risk assessment, one thing usually not considered adequately is a company’s sales culture. To see the consequences of that, one need look no further than GSK’s corruption troubles in China—but, CW blogger Tom Fox writes, the reforms GSK has implemented with its sales force are ...

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.